SlowBull
The Business Brief THURSDAY, 3 SEPTEMBER 2026
← All stories
Markets

The hidden scale-out problem behind CAR-T’s growth

1 source ·1 article ·2h ago

CAR-T’s commercial challenge is making thousands of patient-specific manufacturing runs behave like one reliable system. "In vivo" production techniques could be one solution.

Covered by 1 outlet

Biopharmadive 1

All coverage · 1 article

BioPharma Dive ·2h ago

The hidden scale-out problem behind CAR-T’s growth

CAR-T’s commercial challenge is making thousands of patient-specific manufacturing runs behave like one reliable system. "In vivo" production techniques could be one solution.